Marine-derived n-3 fatty acids therapy for stroke

Celia Gabriela Alvarez Campano (Corresponding Author), Mary J. Macleod, Lorna S. Aucott, Frank Thies

Research output: Contribution to journalArticle

Abstract

Background

With stroke burden increasing, there remains a need to identify therapeutic options that ameliorate the acute insult. There is substantial evidence for a neuroprotective effect of marine-derived n-3 polyunsaturated fatty acids (PUFAs), associated with better functional outcomes in experimental stroke models.

Objectives

To assess the effects of administration of marine-derived n-3 PUFAs on functional outcomes and dependence in people with stroke.

Our secondary outcomes were vascular-related death, recurrent events, incidence of other type of stroke, adverse events, quality of life, and mood.
Original languageEnglish
JournalStroke
Early online date26 Sep 2019
DOIs
Publication statusE-pub ahead of print - 26 Sep 2019

Fingerprint

Omega-3 Fatty Acids
Stroke
Neuroprotective Agents
Therapeutics
Blood Vessels
Theoretical Models
Quality of Life
Incidence

Keywords

  • stroke
  • treatment
  • functional recovery
  • marine-derived n-3 PUFAs

Cite this

Marine-derived n-3 fatty acids therapy for stroke. / Alvarez Campano, Celia Gabriela (Corresponding Author); Macleod, Mary J.; Aucott, Lorna S.; Thies, Frank.

In: Stroke, 26.09.2019.

Research output: Contribution to journalArticle

@article{9663957f0b30485f934423d90b1bb2aa,
title = "Marine-derived n-3 fatty acids therapy for stroke",
abstract = "BackgroundWith stroke burden increasing, there remains a need to identify therapeutic options that ameliorate the acute insult. There is substantial evidence for a neuroprotective effect of marine-derived n-3 polyunsaturated fatty acids (PUFAs), associated with better functional outcomes in experimental stroke models.ObjectivesTo assess the effects of administration of marine-derived n-3 PUFAs on functional outcomes and dependence in people with stroke.Our secondary outcomes were vascular-related death, recurrent events, incidence of other type of stroke, adverse events, quality of life, and mood.",
keywords = "stroke, treatment, functional recovery, marine-derived n-3 PUFAs",
author = "{Alvarez Campano}, {Celia Gabriela} and Macleod, {Mary J.} and Aucott, {Lorna S.} and Frank Thies",
note = "Funding Sources CG Alvarez Campano’s PhD studies are funded by the Mexican Council for Science and Technology (CONACYT) and the Institute of Innovation and Technology Transfer (I2T2), grant number 457349. Acknowledgments This paper is based on a Cochrane Review published in The Cochrane Library 2019, Issue 6 (see www.thecochranelibrary.com for information). Cochrane Reviews are regularly updated as new evidence emerges and in response to feedback, The Cochrane Library should be consulted for the most recent version of the review.",
year = "2019",
month = "9",
day = "26",
doi = "10.1161/STROKEAHA.119.026919",
language = "English",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Marine-derived n-3 fatty acids therapy for stroke

AU - Alvarez Campano, Celia Gabriela

AU - Macleod, Mary J.

AU - Aucott, Lorna S.

AU - Thies, Frank

N1 - Funding Sources CG Alvarez Campano’s PhD studies are funded by the Mexican Council for Science and Technology (CONACYT) and the Institute of Innovation and Technology Transfer (I2T2), grant number 457349. Acknowledgments This paper is based on a Cochrane Review published in The Cochrane Library 2019, Issue 6 (see www.thecochranelibrary.com for information). Cochrane Reviews are regularly updated as new evidence emerges and in response to feedback, The Cochrane Library should be consulted for the most recent version of the review.

PY - 2019/9/26

Y1 - 2019/9/26

N2 - BackgroundWith stroke burden increasing, there remains a need to identify therapeutic options that ameliorate the acute insult. There is substantial evidence for a neuroprotective effect of marine-derived n-3 polyunsaturated fatty acids (PUFAs), associated with better functional outcomes in experimental stroke models.ObjectivesTo assess the effects of administration of marine-derived n-3 PUFAs on functional outcomes and dependence in people with stroke.Our secondary outcomes were vascular-related death, recurrent events, incidence of other type of stroke, adverse events, quality of life, and mood.

AB - BackgroundWith stroke burden increasing, there remains a need to identify therapeutic options that ameliorate the acute insult. There is substantial evidence for a neuroprotective effect of marine-derived n-3 polyunsaturated fatty acids (PUFAs), associated with better functional outcomes in experimental stroke models.ObjectivesTo assess the effects of administration of marine-derived n-3 PUFAs on functional outcomes and dependence in people with stroke.Our secondary outcomes were vascular-related death, recurrent events, incidence of other type of stroke, adverse events, quality of life, and mood.

KW - stroke

KW - treatment

KW - functional recovery

KW - marine-derived n-3 PUFAs

U2 - 10.1161/STROKEAHA.119.026919

DO - 10.1161/STROKEAHA.119.026919

M3 - Article

JO - Stroke

JF - Stroke

SN - 0039-2499

ER -